Icon
Image
pph-green-icon
Postpartum Hemorrhage
Icon White
Image
Post Partum Haemorrage

Earlier this year, FIGO and the Chien-Tien Hsu Research Foundation partnered together to enable two young health professionals who are beginning their career in gynaecologic oncology to attend the FIGO World Congress 2023 and visit a gynaecologic oncology centre in Paris to gain clinical and research experience. 

3 mins read
Meet the winners of the FIGO/Chien-Tien Hsu Fellowship in Gynaecologic Oncology 2023

Dr Razan Khogali Othman is a recent medical school graduate from the National Ribat University in Sudan. Throughout her time in university, she focused on the sexual and reproductive health and rights of women and worked with global feminist organisations to address issues such as gender based violence and maternal health. She shares her experiences volunteering at Wad Madani Hospital for Obstetrics and Gynaecology in the context of the war that started in April 2023, highlighting the health needs of women and pressures faced by health care workers in this crisis. 

4 mins read
Dr Razan Khogali Othman on the war in Sudan and the challenges to deliver health care services to women

Dr Ruth Wamae is Project Manager for the Accelerating Measurable Progress and Leveraging Investments for Postpartum Haemorrhage Impact (AMPLI-PPHI) initiative at the Kenya Obstetrical and Gynaecological Society (KOGS).  She shares her professional experiences responding to PPH and highlights the importance of collaboration to prevent the maternal deaths and disabilities caused by it. 

4 mins read
Dr Ruth Wamae shares her experiences preventing postpartum haemorrhage in Kenya

Marking World Patient Safety Day 2022 

Medication-related harm accounts for up to half of the overall preventable harm in medical care. Patients in low- and middle-income countries are twice as likely to experience preventable medication harm than patients in high-income countries. Considering this huge burden of harm, the World Health Organization has selected “medication safety” as the theme for World Patient Safety Day 2022 on 17 September.  

3 mins read
World Patient Safety Day 2022: medication safety for the prevention and treatment of postpartum haemorrhage (PPH)

FIGO’s Combatting Postpartum Haemorrhage (PPH) Project provides technical support to selected regional and national societies and professional maternal health leaders to help accelerate PPH control efforts for improved PPH diagnosis and management through the use of PPH Emergency Care Using a Bundle Approach (PPH EmC) .  

6 mins read
Lessons from the field: implementing FIGO’s combatting PPH project in Kenya

In August 2022, Unitaid announced a US$45 million investment to increase access to lifesaving products that prevent and treat severe bleeding after childbirth.

2 mins read
FIGO joins international consortium to introduce quality-assured postpartum haemorrhage (PPH) drugs in LMICs

FIGO’s Committee on Childbirth and Postpartum Haemorrhage (formerly Safe Motherhood and Newborn Health), in collaboration with global experts, has published a new supplement in the 157(S1) issue of the International Journal of Gynecology and Obstetrics (IJGO) on 17 March 2022. The supplement provides a comprehensive review and best practices for the prevention and management of postpartum haemorrhag

3 mins read
New IJGO Supplement: FIGO recommendations on the management of postpartum haemorrhage, 2022